Ensysce Biosciences, Inc.

ENSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-3 Oct 23, 2026 S-3
8-K/A Oct 16, 2026 8-K/A
8-K Sep 29, 2026 8-K
8-K Aug 25, 2026 8-K
8-K Aug 24, 2026 8-K
D Aug 20, 2026
SCHEDULE 13D/A Aug 18, 2026
4 Aug 18, 2026 4
10-Q Aug 13, 2026 10-Q
8-K Aug 13, 2026 8-K
3 Aug 10, 2026 3
8-K/A Aug 6, 2026 8-K/A
8-K Aug 6, 2026 8-K
8-K Jul 15, 2026 8-K
EFFECT Jun 26, 2026
S-3 Jun 4, 2026 S-3
8-K May 22, 2026 8-K
10-Q May 15, 2026 10-Q
8-K May 15, 2026 8-K
S-8 Apr 30, 2026 S-8
EFFECT Apr 15, 2026
CORRESP Apr 14, 2026
UPLOAD Apr 13, 2026
S-3 Apr 9, 2026 S-3
8-K Apr 8, 2026 8-K
← Newer Page 1 of 22 · 545 filings Older →